Don J Diamond Selected Research

Don J Diamond Research Topics

Disease

34	Infections 01/2022 - 02/2004
27	Neoplasms (Cancer) 01/2022 - 11/2002
26	Vaccinia 06/2022 - 04/2003
8	Communicable Diseases (Infectious Diseases) 11/2020 - 11/2002
6	Cytomegalovirus Infections (Inclusion Disease) 12/2021 - 02/2004
5	Viremia 01/2020 - 04/2006
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 06/2009
4	Virus Diseases (Viral Diseases) 07/2015 - 09/2003
3	Respiratory Tract Infections (Respiratory Tract Infection) 06/2022 - 09/2021
3	Weight Loss (Weight Reduction) 06/2022 - 09/2021
3	Fever (Fevers) 01/2022 - 10/2007
3	Fatigue 01/2022 - 10/2007
3	Lymphoma (Lymphomas) 01/2022 - 07/2015
3	Leukemia 11/2021 - 08/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2011
3	Adenocarcinoma 01/2020 - 01/2011
3	Congenital Abnormalities (Deformity) 10/2017 - 12/2015
3	Tetanus 02/2016 - 11/2002
3	Brain Neoplasms (Brain Tumor) 10/2012 - 06/2005
2	Lung Injury 01/2022 - 09/2021
2	COVID-19 01/2022 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 11/2013
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2019 - 08/2004
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2014 - 09/2014
2	Glioma (Gliomas) 10/2012 - 02/2011
2	Melanoma (Melanoma, Malignant) 10/2012 - 06/2011
2	Human Influenza (Influenza) 04/2011 - 05/2010
2	Progressive Multifocal Leukoencephalopathy 06/2006 - 09/2005
2	HIV Infections (HIV Infection) 05/2005 - 03/2005
2	Sarcoma (Soft Tissue Sarcoma) 08/2004 - 03/2003
1	Disease Progression 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Birth Weight (Birth Weights) 12/2021
1	Reinfection 12/2021
1	Carcinogenesis 01/2020
1	Metaplasia 01/2019
1	Ovarian Epithelial Carcinoma 01/2018
1	Herpesviridae Infections (Herpesvirus Infection) 01/2018

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 06/2022 - 11/2002
23	AntigensIBA 06/2022 - 05/2002
12	EpitopesIBA 10/2017 - 11/2002
11	Neutralizing AntibodiesIBA 01/2018 - 04/2004
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2003
9	Peptides (Polypeptides)IBA 01/2018 - 05/2002
7	Glycoproteins (Glycoprotein)IBA 12/2021 - 04/2004
6	OligodeoxyribonucleotidesIBA 10/2012 - 08/2004
5	AntibodiesIBA 01/2022 - 11/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2005
4	COH04S1 COVID-19 vaccineIBA 06/2022 - 09/2021
4	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2007
4	Subunit VaccinesIBA 12/2021 - 03/2006
4	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2011
4	CytokinesIBA 06/2016 - 05/2004
4	HLA-A*02:01 antigenIBA 04/2012 - 11/2002
3	Gemcitabine FDA Link 01/2021 - 01/2011
3	EnzymesIBA 01/2020 - 10/2007
3	InterferonsIBA 01/2020 - 09/2003
3	Protein Subunit VaccinesIBA 01/2019 - 04/2012
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2016 - 08/2011
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 09/2015 - 12/2012
3	SurvivinIBA 11/2014 - 01/2011
2	COVID-19 VaccinesIBA 01/2022 - 09/2021
2	Broadly Neutralizing AntibodiesIBA 01/2022 - 09/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 04/2011
2	Chimeric Antigen ReceptorsIBA 11/2021 - 07/2015
2	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 09/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 09/2011
2	Serine Proteases (Serine Protease)IBA 09/2015 - 08/2011
2	MVA vaccineIBA 09/2014 - 07/2010
2	Therapeutic UsesIBA 03/2013 - 03/2003
2	Carbon Nanotubes (Carbon Nanotube)IBA 10/2012 - 02/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2012 - 07/2010
2	PhosphoproteinsIBA 02/2005 - 08/2004
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2005 - 11/2002
1	CD19-specific chimeric antigen receptorIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 12/2021
1	pyrimidineIBA 01/2021
1	baicaleinIBA 12/2020
1	Chloroquine (Aralen)FDA LinkGeneric 12/2020
1	epacadostatIBA 01/2020
1	Azacitidine (5 Azacytidine)FDA Link 01/2020
1	MethyltransferasesIBA 01/2020
1	ChemokinesIBA 01/2020
1	TESIBA 01/2020
1	DNA Transposable Elements (Element, IS)IBA 01/2020
1	Cytomegalovirus VaccinesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	PlatinumIBA 01/2018

Therapy/Procedure

14	Therapeutics 01/2022 - 04/2006
8	Immunotherapy 10/2012 - 11/2002
4	Cell Transplantation 01/2022 - 11/2002
3	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2006
2	Transplantation 10/2018 - 03/2007
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2011
2	Injections 11/2014 - 04/2012
1	Personal Protective Equipment 01/2020
1	Aftercare (After-Treatment) 01/2018